No higher risk of acute leukaemia in close relatives

December 15, 2011

(Medical Xpress) -- Parents, siblings and children of patients with the most common form of acute leukemia do not run a higher risk of developing the disease as was once believed, according to a new study from the Swedish medical university Karolinska Institutet.

Every year, some 400 people in Sweden are diagnosed with (AML), the most common form of . Just like for other forms of the disease, the causes of AML are largely unknown and are probably a combination of hereditary and environmental factors. According to earlier studies, first-degree relatives (parents, siblings and children) of patients with AML run three times the normal risk of developing the disease.

However, a joint study conducted by researchers at Karolinska Institutet and the USA's National Institutes of Health (NIH) has now shown that this is not the case.

The teams studied over 20,000 first-degree relatives of and compared the results with over 90,000 relatives of a and found no higher risk for AML or other blood tumour diseases with the exception of polycythemia vera, a disorder leading to the over-production of .

"Our results show that close relatives of AML patients can feel reassured that they run no higher risk than normal of developing AML," says Magnus Björkholm, professor at Karolinska Institutet's Department of Medicine (Solna) and consultant at Karolinska University Hospital.

The researchers also studied relatives of patients with myelodysplastic syndrome (MDS), which can be a precursor of leukaemia. Here too they observed no increase in risk for blood tumour diseases in first-degree relatives.

"In our view, the lack of a familial increase in risk of AML and MDS contrasts sharply with other blood tumour diseases, for which there is often a significant familial connection," says Professor Björkholm.

More information: Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes, Journal of Clinical Oncology, published online before print December 12, 2011, doi: 10.1200/JCO.2011.37.1203

Related Stories

Two-faced leukemia?

December 12, 2011

One kind of leukemia sometimes masquerades as another, according to a study published online this week in the Journal of Experimental Medicine.

Recommended for you

New treatment options for a fatal leukemia

July 27, 2015

In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...

Exciting results from cancer immunoagent study

July 20, 2015

(Medical Xpress)—Cancer therapies have improved incrementally over the years, but cancer treatment largely remains analogous to forest fire suppression, in which the spread of fire is contained with deliberate controlled ...

Lymphomas tied to metabolic disruption

July 17, 2015

Researchers from the School of Medicine at The University of Texas Health Science Center at San Antonio have found evidence that directly links disrupted metabolism (energy production in cells) to a common and often fatal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.